Font Size: a A A
Keyword [Chronic Myelogenous Leukemia]
Result: 101 - 120 | Page: 6 of 10
101. The Clinical Analysis Of Five Cases With Chronic Myelogenous Leukemia With Thrombocythemia Onset
102. MiR-29b Suppresses Cell Proliferation And Induces Apoptosis In CML Cells
103. Microfluidic Chip Technology To Analyse The Expression Of Myeloperoxidase In Patients With Chronic Myelogenous Leukemia
104. The Effect Of Aminosteroid Derivatives On Human K562and MMG-olcell Lines Of Chronic Myelogenous Leukemia
105. Effects Of Recombinant Adenovirus-mediated ARE/SUZ12-regulated TK/GCV On Chronic Myelogenous Leukemia Blast Crisis Cells
106. The RalA GTpase Activity In Malignant Transformation Of Chronic Myelogenous Leukemia (CML) Cells And Intervention Effects Of MiR-181a
107. Imatinib Induces Bim Expression And Apoptosis In Chronic Myelogenous Leukemia Cells Via P38/H2AX Pathway
108. The Mechanism Of Synergy Of BH3Mimetics And Paclitaxel In Chronic Myeloid Leukemia
109. Preliminary Observation Of Second-generation Tyrosine Kinase Inhibitors In The Treatment Of Chronic Myelogenous Leukemia
110. Efficacy Of Switching To Nilotinib Among Patients Failed To Achieve A BCR-ABL Transcript Level ≤10% After 6 Months After Imatinib Initiation
111. Observation On The Efficacy Of Dasatinib For Chronic Myelogenous Leukemia Patients In Advanced Phase
112. P38 And JNK-regulated H2AX Phosphorylation Is Essential For Apoptosis In Chronic Myelogenous Leukemia Cells Induced By Resveratrol
113. Clinical Follow Up Of Patients Receiving Tyrosine Kinase Inhibitors For The Treatment Of Chronic Myelogenous Leukemia
114. Studies Of Radix Saposhnikoviae Extract Combined With ATO On Acute And Chronic Myelogenous Leukemia In Vivo And In Vitro
115. Detection Of BCR-ABL Fusion Gene With Endothelial Progenitor Cells In Chronic Myelogenous Leukemia And Its Clinical Significance
116. The Expression And Meaning Of MiR-328 And C/EBP α In Patients With Chronic Myelogenous Leukemia
117. Left-handed Alkannin Research On The Effect Of Chronic Myelogenous Leukemia
118. Research On PR1 Specific Cytotoxic T Lymphocytes Of 28 Cases HLA-A0201 Positive Chronic Myelogenous Leukemia
119. The Traditional Chinese Medicine Of Berberine Overcomes Imatinib-resistance In Chronic Myelogenous Leukemia
120. A Cost-effectiveness Analysis Of Dasatinib For The Treatment Of Imatinib Mesylate Resistant Chronic Myelogenous Leukaemia
  <<First  <Prev  Next>  Last>>  Jump to